Vivek Nambiar

2.4k total citations
37 papers, 549 citations indexed

About

Vivek Nambiar is a scholar working on Neurology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Vivek Nambiar has authored 37 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Neurology, 18 papers in Epidemiology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Vivek Nambiar's work include Acute Ischemic Stroke Management (17 papers), Autoimmune Neurological Disorders and Treatments (9 papers) and Cerebrovascular and Carotid Artery Diseases (8 papers). Vivek Nambiar is often cited by papers focused on Acute Ischemic Stroke Management (17 papers), Autoimmune Neurological Disorders and Treatments (9 papers) and Cerebrovascular and Carotid Artery Diseases (8 papers). Vivek Nambiar collaborates with scholars based in India, Canada and United States. Vivek Nambiar's co-authors include Andrew M. Demchuk, Bijoy K. Menon, Mayank Goyal, Mohammed Almekhlafi, Muneer Eesa, Emmad Qazi, Michael D. Hill, Sachin Mishra, Jamsheed A. Desai and Ondřej Volný and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Stroke.

In The Last Decade

Vivek Nambiar

33 papers receiving 542 citations

Peers

Vivek Nambiar
Matthias Bechstein Germany
Timothy Watson Canada
Heitor Alves Brazil
Bruna Garbugio Dutra Netherlands
Kanta Tanaka Japan
C. Schwark Germany
Zarina Assis Canada
Reza Kabiri Germany
Bryan Ludwig United States
Marcel Wolf Germany
Matthias Bechstein Germany
Vivek Nambiar
Citations per year, relative to Vivek Nambiar Vivek Nambiar (= 1×) peers Matthias Bechstein

Countries citing papers authored by Vivek Nambiar

Since Specialization
Citations

This map shows the geographic impact of Vivek Nambiar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivek Nambiar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivek Nambiar more than expected).

Fields of papers citing papers by Vivek Nambiar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vivek Nambiar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivek Nambiar. The network helps show where Vivek Nambiar may publish in the future.

Co-authorship network of co-authors of Vivek Nambiar

This figure shows the co-authorship network connecting the top 25 collaborators of Vivek Nambiar. A scholar is included among the top collaborators of Vivek Nambiar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vivek Nambiar. Vivek Nambiar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kannoth, Sudheeran, et al.. (2025). MOG positive primary autoimmune meningitis mimicking tuberculous meningitis: a case series. BMJ Neurology Open. 7(1). e000999–e000999.
2.
3.
4.
Kannoth, Sudheeran, et al.. (2023). The prevalence and clinical phenotype of dual seropositive neuromyelitis optica spectrum disorders at a national reference center in South Asia. Multiple Sclerosis and Related Disorders. 75. 104736–104736. 1 indexed citations
5.
Mathai, Annamma, et al.. (2023). Cerebrospinal fluid indices as predictors of treatment response in autoimmune encephalitis. Multiple Sclerosis and Related Disorders. 79. 104996–104996. 2 indexed citations
6.
Kate, Mahesh, Vivek Nambiar, Sunil K. Narayan, et al.. (2023). Ayurvedic Treatment in the Rehabilitation of Ischemic Stroke Patients in India: A Randomized Controlled Trial Study Protocol. Cerebrovascular Diseases. 52(6). 609–615. 1 indexed citations
7.
Nambiar, Vivek, et al.. (2022). One-year mortality after acute stroke: a prospective cohort study from a comprehensive stroke care centre, Kerala, India. BMJ Open. 12(11). e061258–e061258. 6 indexed citations
8.
Nambiar, Vivek, et al.. (2022). Autoimmune parkinsonism with faciobrachiocrural dystonic seizures: a new phenotype of leucine-rich glioma-inactivated 1 (LGI1) autoimmunity. Acta Neurologica Belgica. 122(5). 1323–1328. 3 indexed citations
9.
Menon, Vivek, et al.. (2022). Automated ASPECTS Classification in Acute Ischemic Stroke using EfficientNetV2. 2022 IEEE 7th International conference for Convergence in Technology (I2CT). 1–6. 5 indexed citations
10.
Nambiar, Vivek, et al.. (2022). Fluoxetine or Venlafaxine for Early Post Stroke Depression. Neurology India. 70(6). 2407–2410. 2 indexed citations
11.
Nambiar, Vivek, et al.. (2021). Acute Ischemic Stroke in Children – Should We Thrombolyze?. Annals of Indian Academy of Neurology. 25(1). 21–25. 2 indexed citations
12.
Sankaran, Ravi, et al.. (2018). A prospective study on the effects of Ayurvedic massage in post-stroke patients. Journal of Ayurveda and Integrative Medicine. 10(2). 126–130. 9 indexed citations
13.
Kannoth, Sudheeran, et al.. (2017). Expanding spectrum of contactin-associated protein 2 (CASPR2) autoimmunity—syndrome of parkinsonism and ataxia. Neurological Sciences. 39(3). 455–460. 25 indexed citations
14.
Nambiar, Vivek, et al.. (2017). Successful revascularization of acute middle cerebral artery occlusion by intravenous thrombolysis while on apixaban. Annals of Indian Academy of Neurology. 20(2). 161–161. 2 indexed citations
15.
Kannoth, Sudheeran, et al.. (2016). Autoimmune atypical parkinsonism — A group of treatable parkinsonism. Journal of the Neurological Sciences. 362. 40–46. 28 indexed citations
16.
Nambiar, Vivek, et al.. (2016). Cerebral venous thrombosis in refractory idiopathic thrombocytopenia treated with eltrombopag. Annals of Indian Academy of Neurology. 19(4). 532–533. 6 indexed citations
17.
18.
James, Emmanuel, et al.. (2015). Impact of clinical pharmacist’s interventions on health outcomes in post stroke patients. 7. 1 indexed citations
19.
Menon, Bijoy K., Emmad Qazi, Vivek Nambiar, et al.. (2014). Abstract 7: Differential Effect of Baseline Cta Collateral Status on Clinical Outcomes in Patients Enrolled in the Ims-3 Trial. Stroke. 45(suppl_1). 4 indexed citations
20.
Bharucha, Nadir E., et al.. (2009). Review of seizures and status epilepticus in HIV and tuberculosis with preliminary view of Bombay hospital experience. Epilepsia. 50(s12). 64–66. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthias Bechstein Breakdown of academic impact, for papers by Timothy Watson Breakdown of academic impact, for papers by Heitor Alves Breakdown of academic impact, for papers by Bruna Garbugio Dutra Breakdown of academic impact, for papers by Kanta Tanaka Breakdown of academic impact, for papers by C. Schwark Breakdown of academic impact, for papers by Zarina Assis Breakdown of academic impact, for papers by Reza Kabiri Breakdown of academic impact, for papers by Bryan Ludwig Breakdown of academic impact, for papers by Marcel Wolf
Rankless by CCL
2026